Science Talk
With our Science Talk blog, we hope to lift the lid on the black box that is the ICR: to show you inside our labs, to introduce you to a few of the people here who make the discoveries, and to allow them to tell some of the stories behind the science. We try to put our discoveries in a wider scientific context, and give an idea of how our science is actually done. We also give you the view from the ICR of important developments in the wider world of cancer research.
Patient records – the key to future cancer treatments
The challenges of big data for cancer drug discovery
The trials and tribulations of tackling triple-negative breast cancer
We wrote in this blog a few weeks ago about Dr Nicholas Turner’s call for researchers to meet the challenge of triple-negative breast cancer – the most hard-to-treat type with the worst outlook for women. Dr Turner has expanded on that theme – along with Dr Jorge Reis-Filho, a former colleague here at The Institute of Cancer Research, London – in a new review.
Do we need intensive follow-ups for early caught breast cancer?
Developing the next generation of cancer drugs - we need to work together to succeed
New team leaders share their vision for future research (Part 2): cancer imaging
New team leaders share their vision for future research (Part 1): cancer evolution
Fred Sanger: the giant of genomics
Why we need smarter clinical trials for cancer treatments
Penile Cancer – new hope for a rare male cancer
Artificial intelligence uses biggest disease database to fight cancer
Tackling the rarer causes of breast cancer
Targeting the epigenome
How chemistry and biology work together to make drugs
The UK’s biggest cancer conference
Old drugs, new tricks: Thalidomide’s journey back from the wilderness
Finding the right ‘bullet’ against breast cancer: how access to tumour samples could save lives
Europe’s biggest cancer conference gets underway
Breaking through the barriers to targeted therapy